The BioChain has launched a new Policy & Regulatory Landscape resource bringing together selected developments affecting data, artificial intelligence, scientific evidence and regulated digital systems across the European Union, United Kingdom and United States.
A practical hub, not a catalogue of legislation
The resource has been designed as a practical policy hub rather than a catalogue of legislation. Each entry addresses three questions: what is the framework, why does it matter, and where does provenance or evidence governance intersect with it?
Initial coverage includes major European frameworks affecting health data, artificial intelligence and the wider data economy; UK developments affecting data use, secure health-data environments, pharmaceutical data integrity and healthcare AI; and US frameworks affecting electronic records, clinical investigations, health information, data integrity and AI risk management.
Connecting policy language to system evidence
The reason for creating the resource is simple. Regulatory requirements are generally written in legal, policy or quality-management language, while the evidence required to demonstrate what actually happened exists in databases, audit trails, laboratory systems, analytical workflows, infrastructure and operational processes. The difficult part is often connecting the two.
For example, an organisation may understand that access to particular data must be controlled but still need to determine which systems contain those data, how derived results are produced, where audit evidence exists, whether identifiers survive transfers and what evidence would actually be available if a processing activity were challenged later.
That interface is increasingly important as evidence becomes more distributed and computational. AI adds model and version dependencies. Genomic workflows depend upon changing reference resources. Secure data environments can protect sensitive source data while generating outputs that subsequently move into other research or regulatory systems. Cross-border work introduces additional organisational and jurisdictional boundaries.
A living resource
The Policy & Regulatory Landscape sits alongside The BioChain’s technical work and its new Advisory service. It is not legal advice and is not intended to replace specialist regulatory or legal counsel. Instead, it provides an accessible starting point for organisations trying to understand which developments may affect the way their systems create, retain and demonstrate evidence.
The resource will be maintained as a living page, with policies clearly identified by jurisdiction and status and the review date displayed so readers can see when the information was last checked.
Questions & Answers
What jurisdictions does the Policy & Regulatory Landscape cover?
The European Union, United Kingdom and United States, with frameworks affecting data, AI, scientific evidence and regulated digital systems.
Is it legal advice?
No. It is not legal advice and is not intended to replace specialist regulatory or legal counsel — it is a starting point for understanding which developments may affect how systems create and demonstrate evidence.
How is each entry structured?
Each addresses three questions: what the framework is, why it matters, and where provenance or evidence governance intersects with it.
Will it be kept up to date?
Yes. It is maintained as a living page, with each entry’s jurisdiction, status and last-reviewed date displayed.